MiRNA Tools And Services Market Research, 2031
The global mirna tools and services market was valued at $311.86 million in 2021, and is projected to reach $1.8 billion by 2031, growing at a CAGR of 19.3% from 2022 to 2031.
The small non-coding gene miRNA (micro-RNA) affects the expression of other genes. Development & differentiation, apoptosis, immunological response, and inflammation are all regulated by miRNAs. A miRNA tool kit gives researchers with convenient tools to utilize when investigating this phenomenon at its most fundamental level, allowing them to gain a better understanding of how it works faster than attempting to create an individual test from start.
The growth of miRNA tools and services industry is driven by increase in the incidence of chronic diseases, rise in the number of cancer cases, increase in funding in gene manipulation therapies research& innovative drug development methodologies that use RNAi-based approaches . Furthermore, another element driving the growth of the miRNA tools and services market share include expensive cost associated with drug research as well as the restricted therapeutic options currently accessible, which drives diagnostic businesses to develop revolutionary techniques based on miRNAs.
The market is expected to witness significant growth owing to the rise in incidence of cancer and cardiovascular diseases. Moreover, use of bioinformatics and technologically advanced systems (such as NGS) are set to drive the market growth and the potential of miRNAs to act as candidates for diagnostic biomarkers are anticipated to further contribute to the demand for miRNA globally. However, the challenges related to quantification and the development of in-house miRNA research tools such as microarrays are expected to impede the market growth.
Technological developments are a new trend in Micro RNA research, resulting in significant progress in miRNA technology. In recent years, manufacturers and researchers have been inspired to develop new solutions due to increased technological improvements in the essential phases of miRNA expression profiling, target gene identification, and validation. HTG Molecular Diagnostics Inc, for example, launched a comprehensive panel for miRNA expression analysis, the HTG EdgeSeq mouse miRNA whole transcriptome test, in August 2018, for use in preclinical functional investigations and translational medicine.
Furthermore, continuing research and clinical trials for miRNA broaden its clinical and preclinical research uses. A rising body of evidence suggests that miRNAs have great utility as drug resistance modulators, biomarkers for pathogenic diseases, or medicines for medical intervention in human health disorders. As a result, increasing the number of clinical trials for evaluating the efficacy of miRNA in the treatment of many chronic illnesses is one of the significant factors fueling the growth of the miRNA market throughout the forecast period. These factors are likely to boost the miRNA Tools and Services market.
Asia-Pacific possesses high market potential, owing to the rise in incidence of chronic disorders and increase in researches undertaken to explore the role of microRNAs in the development, treatment, and diagnosis such as cancer.
The World Health Organization (WHO) on January 30, 2021 declared COVID-19 as a pandemic and general wellbeing crisis of international concern. COVID-19 has impacted around 210 countries across the globe. Owing to the COVID-19 pandemic, state-run administrations across the globe declared inescapable lockdowns as well as social distancing measures to forestall breakdown of the healthcare structure. In addition, states have additionally given constraints and preventions on undertakings and elective surgeries. These obstructions continue to influence the growth of different industries, and enhanced response toward these regulations affects the industry. The distribution, production, and store network have been impacted, due to lockdowns across the globe.Similarly, the miRNA tools and services market size had a negative impact during the pandemic as the manufacturing was delayed due to social distancing norms and lockdown imposed all across the globe. Although, the miRNA tools and services market growth is anticipated to grow in upcoming years which is anticipated to propel the growth of market. As the market is expected to grow with increase in in infectious virus as research proves cc-miRNAs can be used as a therapeutics for covid-19 pandemic. Hence, overall the pandemic had a negative impact on miRNA tools & services market.
The mirna tools and services market is segmented into Product and Services, Technology and End User.
The miRNA tools and services market is segmented on the basis of product, technology, end user, and region. By product, the industry is fragmented into research tools and services. The research tool segment is segmented into kits, reagents, and other consumables and service segment is fragmented into miRNA extraction services, quantification services, microarray services, sequencing services, functional studies services, and others. By technology the market is segregated into extraction tools, qrt-pcr, next generation sequencing, microarray, functional analysis tools and others.
By end user, the market is classified into research & academic institutes, in vitro diagnostics, pharma & biotech companies, and contract research organization. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Segment Review by Product
By product, research tools segment dominated the market in 2021 with a revenue of $252.62 million. Growth of the segment is attributed to increasing incidence of chronic diseases such as cancer and cardiovascular disorders, research funding by various companies and recent developments such as use of bioinformatics for the research has further driven the market growth during miRNA tools and services market forecast.
Segment Review, Technology
By technology type, the qRT-PCR segment dominated the market in 2021 with a revenue of $93.49 million. The growth of the segment can be attributed to surge in in the incidence of chronic diseases, rise in the number of cancer cases, increase in funding in gene manipulation therapies research& innovative drug development methodologies that use RNAi-based approaches.
Segment Review, End User
By end user, research & academic institutes segment dominated the market in 2021 with a revenue of $142.74 million. The use of bioinformatics and technologically advanced systems (such as NGS) are set to drive the market growth and the potential of miRNAs to act as candidates for diagnostic biomarkers are anticipated to further contribute to the demand for miRNA globally.
Region Type Segment Review
Region wise, North America dominated the global market in 2021 with a revenue of $136.1 million, which is attributed to increase in the geriatric population and cancer. Asia-Pacific possesses high market potential, owing to the rise in incidence of chronic disorders and increase in researches undertaken to explore the role of microRNAs in the development, treatment, and diagnosis such as cancer.
Major key players that operate in the global miRNA tools and services market are Agilent Technologies, Bio-Rad laboratories, General Electrics, Integrated DNA Technologies, Koninklijike Philips N.V., Merck & Co., Omega Bio-Tek, Promega Corporation, Qiagen, and Thermo Fischer Scientific Inc.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the mirna tools and services market analysis from 2021 to 2031 to identify the prevailing miRNA tools and services market opportunity.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the mirna tools and services market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global mirna tools and services market trends, key players, market segments, application areas, and market growth strategies.
miRNA Tools and Services Market Report Highlights
| Aspects | Details |
 By Product and Services |
|
 By Technology |
|
 By End User |
|
 By Region |
|
 Key Market Players | Promega Corporation, Norgen Biotek Corp., Agilent Technologies INC., New England Biolabs, General Electric Company, Bio-Rad Laboratories, Inc., Qiagen N.V., GeneCopoeia, Inc., Illumina, Inc., Thermo Fisher Scientific inc |
Analyst Review
A group of tiny, non-coding RNA molecules known as miRNA regulates gene expression after transcription. Cell cycle control, stem cell differentiation, immunological modulation, viral replication, and metabolic control are just a few of the basic functions that these chemicals affect. Because the aforementioned processes play a role in the pathology of a variety of diseases, miRNA tests can aid in disease treatment. Furthermore, because miRNAs are easier to modify than proteins, they are more valuable for clinical diagnostics and therapies.
Factors such as cancer, autoimmunity, and cardiovascular diseases are considered to be growth factors for miRNA tools & services market. However, market growth is hampered by quantification issues and the emergence of in-use techniques such as microarray. Furthermore, miRNA molecules have unique qualities, such as greater tissue and organ specificity and the capacity to easily penetrate the blood–brain barrier, which make them a promising candidate for usage as biomarkers for a number of neurological disorders, boosting the market growth.
In addition, North America accounted for the largest miRNA tools and services share, which is attributed to surge in cancer, chronic disorders and cardiovascular disorders.
The upcoming trends of MiRNA Tools and Services Market includes rising prevalence of chronic diseases and the increased number of studies being conducted to investigate the function of microRNAs in the development, treatment, and diagnosis of diseases such as cancer.
North America is the largest regional market for MiRNA Tools and Services Market.
Chronic diseases such as cancer and Micro RNA research are the leading application of MiRNA Tools and Services Market.
Major key players that operate in the global miRNA tools and services market are Agilent Technologies, Bio-Rad laboratories, General Electrics, Integrated DNA Technologies, Koninklijike Philips N.V., Merck & Co., Omega Bio-Tek, Promega Corporation, Qiagen, and Thermo Fischer Scientific Inc.
The global miRNA tools and services market was valued $311.86 million in 2021 and expected to reach $1,822.15 million by 2031, with a CAGR of 19.3% from 2022 to 2031.
Loading Table Of Content...
